Ayşen Zeybek

Ayşen Zeybek

Auto-generated profile, based on publicly available information

Ayşen Zeybek

Department of Emergency Medicine, University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2023 in Eurasian Journal of Toxicology
Verified
Journal Article
Closed access
SKSerbülent Kılıç
Serbülent Kılıç
CCCemal İlKer Cander
Cemal İlKer Cander
AZAyşen ZEYBEK
Ayşen ZEYBEK
MYMelih Yüksel
Melih Yüksel
Objective: The aim of this study was to investigate the epidemiology of dog and cat bite cases in Bursa, Turkey through 2018–2022. Materials and Methods: A retrospective patient review was carried out. This study was conducted in the department of the Emergency Medicine of Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey. The injury patterns and epidemiologic data of the patients were evaluated. A total of 92 animal bite cases were reviewed. Results and Conclusion: This study was enrolled 49 men (53.3%) and 43 women (46.7%) with an average age of 37.09± 16.65 years. None of them died as a consequence of animal bite. The findings indicate that a significant correlation was found between the site of injury, the type of wound, antibiotic use, and the species of the biting animals [(p=0.001), (p

21 August 2023 in Global Emergency and Critical Care
Verified
Journal Article
Closed access
SKSerbülent Kılıç
Serbülent Kılıç
AZAyşen Zeybek
Ayşen Zeybek
MYMelih Yüksel
Melih Yüksel
MSMUSA SAHIN
MUSA SAHIN

27 March 2026 in Uludağ Üniversitesi Tıp Fakültesi Dergisi
Verified
Journal Article
Closed access
AZAyşen Zeybek
Ayşen Zeybek
MYMelih Yüksel
Melih Yüksel
MAMehmet Oğuzhan Ay
Mehmet Oğuzhan Ay
YIYeşim Işler
Yeşim Işler
HKHalil Kaya
Halil Kaya
SÇSerhat Çakır
Serhat Çakır
This study aimed to investigate the association between admission serum subfatin levels and 28- and 90-day mortality and functional outcomes (Modified Rankin Scale, mRS) in patients diagnosed with ischemic wake-up stroke in the emergency department. Between April 2022 and March 2023, 66 patients presenting with wake-up stroke and 71 healthy controls were prospectively evaluated. Serum subfatin levels were measured by ELISA in all participants. Mortality and mRS scores at 28 and 90 days were recorded for the patient group. Serum subfatin levels were significantly lower in the patient group compared to controls (median: 1.44 ng/dL vs. 1.65 ng/dL; p0.05). Subfatin levels showed significant differences in patients with anterior cerebral artery and superior cerebellar artery involvement (p<0.05). Serum subfatin levels are lower in patients with ischemic wake-up stroke than in healthy controls. However, no significant relationship was found between subfatin levels and short- or medium-term mortality or functional outcomes. Larger studies are needed to validate these findings.